advanced therapies
No safety concerns so far in Sangamo’s groundbreaking gene-editing trial
Andrew McConaghie
advanced therapies, gene editing, gene therapy, Rare diseases, Sangamo
0 Comment
Market Access/ News/ News/ Pharma Market Access/ R&D
First ever ‘off the shelf’ stem cell therapy nears European approval
Richard Staines
advanced therapies, Crohn's disease, gastroenterology, Rare diseases, regulation, stem cell therapy, Takeda, TiGenix
0 Comment
Alofisel recommended for complex perianal fistulas in Crohn’s disease
Vericel hopes for US hit with Maci knee treatment
Richard Staines
advanced therapies, Genzyme, pricing, reimbursement, sales, Sanofi
0 Comment
Tissue engineering product previously flopped in EU.
News/ Pharma Market Access/ UK & Europe
EU regulator wants more advanced therapies
Richard Staines
advanced therapies, market access, regulation
0 Comment
Only a handful of products have reached the market in eight years.